Home/Filings/4/0001415889-23-013337
4//SEC Filing

DIXON WENDY L 4

Accession 0001415889-23-013337

CIK 0001701541other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 5:25 PM ET

Size

5.1 KB

Accession

0001415889-23-013337

Insider Transaction Report

Form 4
Period: 2023-09-15
Transactions
  • Award

    Common Stock

    2023-09-15$3.60/sh+2,986$10,75030,758 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 14, 2023.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0001202283

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:25 PM ET
Size
5.1 KB